{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:41:44Z","timestamp":1776087704468,"version":"3.50.1"},"reference-count":36,"publisher":"FapUNIFESP (SciELO)","issue":"3","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"DOI":"10.1590\/1414-431x20176601","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T04:54:24Z","timestamp":1515646464000},"source":"Crossref","is-referenced-by-count":10,"title":["Penile microvascular endothelial function in hypertensive patients: effects of acute type 5 phosphodiesterase inhibition"],"prefix":"10.1590","volume":"51","author":[{"given":"V.","family":"Verri","sequence":"first","affiliation":[{"name":"Minist\u00e9rio da Sa\u00fade, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.A.","family":"Brand\u00e3o","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tibirica","sequence":"additional","affiliation":[{"name":"Minist\u00e9rio da Sa\u00fade, Brasil; Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2018]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/micc.12067","article-title":"Antihypertensive treatment improves microvascular rarefaction and reactivity in low-risk hypertensive individuals","volume":"20","author":"Kaiser SE","year":"2013","journal-title":"Microcirculation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2003.11.015","article-title":"Non-invasive assessment of microvascular endothelial function by laser doppler flowmetry in patients with essential hypertension","volume":"173","author":"Farkas K","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.HYP.0000249510.20326.72","article-title":"Hypertension: a disease of the microcirculation?","volume":"48","author":"Feihl F","year":"2006","journal-title":"Hypertension"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/cs0970523","article-title":"Maximization of skin capillaries during intravital video-microscopy in essential hypertension: comparison between venous congestion, reactive hyperaemia and core heat load tests","volume":"97","author":"Antonios TF","year":"1999","journal-title":"Clin Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/01.HYP.38.2.238","article-title":"Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction","volume":"38","author":"Serne EH","year":"2001","journal-title":"Hypertension"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.HYP.34.4.655","article-title":"Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality","volume":"34","author":"Antonios TF","year":"1999","journal-title":"Hypertension"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/heart.89.2.175","article-title":"Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension","volume":"89","author":"Antonios TF","year":"2003","journal-title":"Heart"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1097\/HJH.0b013e32830dd0c6","article-title":"Sexual dysfunction: the \u2018prima ballerina\u2019 of hypertension-related quality-of-life complications","volume":"26","author":"Manolis A","year":"2008","journal-title":"J Hypertens"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/CRD.0b013e3181fb7eb8","article-title":"Erectile dysfunction: a disease marker for cardiovascular disease","volume":"19","author":"Shin D","year":"2011","journal-title":"Cardiol Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCOUTCOMES.112.966903","article-title":"Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies","volume":"6","author":"Vlachopoulos CV","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.urology.2011.02.070","article-title":"Brachial flow-mediated dilation correlates with vardenafil response in hypertensive men with vasculogenic erectile dysfunction","volume":"78","author":"Javaroni V","year":"2011","journal-title":"Urology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1743-6109.2009.01624.x","article-title":"Anatomy, physiology, and pathophysiology of erectile dysfunction","volume":"7","author":"Gratzke C","year":"2010","journal-title":"J Sex Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11906-013-0377-9","article-title":"Effectiveness and safety of phosphodiesterase 5 inhibitors in patients with cardiovascular disease and hypertension","volume":"15","author":"Chrysant SG","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.amjmed.2012.08.015","article-title":"Phosphodiesterase type 5 inhibitors improve endothelial function and may benefit cardiovascular conditions","volume":"126","author":"Schwartz BG","year":"2013","journal-title":"Am J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3909\/ricm0679","article-title":"Therapeutic Potentials of phosphodiesterase-5 inhibitors in cardiovascular disease","volume":"15","author":"Nguyen H","year":"2014","journal-title":"Rev Cardiovasc Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.mvr.2012.01.004","article-title":"Evaluation of systemic microvascular endothelial function using laser speckle contrast imaging","volume":"83","author":"Cordovil I","year":"2012","journal-title":"Microvasc Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.mvr.2010.05.012","article-title":"Excellent reproducibility of laser speckle contrast imaging to assess skin microvascular reactivity","volume":"80","author":"Roustit M","year":"2010","journal-title":"Microvasc Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MCA.0000000000000055","article-title":"Impairment of systemic microvascular endothelial and smooth muscle function in individuals with early-onset coronary artery disease: studies with laser speckle contrast imaging","volume":"25","author":"Souza EG","year":"2014","journal-title":"Coron Artery Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mvr.2015.03.006","article-title":"The evaluation of penile microvascular endothelial function using laser speckle contrast imaging in healthy volunteers","volume":"99","author":"Verri V","year":"2015","journal-title":"Microvasc Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tips.2013.05.007","article-title":"Assessment of endothelial and neurovascular function in human skin microcirculation","volume":"34","author":"Roustit M","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jacc.2015.06.1328","article-title":"The cardiometabolic health alliance: working toward a new care model for the metabolic syndrome","volume":"66","author":"Sperling LS","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"627278","DOI":"10.1155\/2012\/627278","article-title":"Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment","volume":"2012","author":"Javaroni V","year":"2012","journal-title":"Int J Hypertens"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00228-002-0456-3","article-title":"Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men","volume":"58","author":"Fogari R","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0895-7061(00)01214-0","article-title":"Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study","volume":"14","author":"Fogari R","year":"2001","journal-title":"Am J Hypertens"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1440-1681.2007.04551.x","article-title":"Nitric oxide, erectile dysfunction and beta-blocker treatment (Mr Noed study): benefit of nebivolol versus metoprolol in hypertensive men","volume":"34","author":"Brixius K","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-114-8-613","article-title":"Effect of antihypertensives on sexual function and quality of life: the Taim study","volume":"114","author":"Wassertheil-Smoller S","year":"1991","journal-title":"Ann Intern Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/HJH.0b013e328342c659","article-title":"Hypertension and sexual dysfunction: time to act","volume":"29","author":"Viigimaa M","year":"2011","journal-title":"J Hypertens"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1742-1241.2010.02563.x","article-title":"Cardiovascular risk, drugs and erectile function - a systematic analysis","volume":"65","author":"Baumhakel M","year":"2011","journal-title":"Int J Clin Pract"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/157016112798829823","article-title":"Hypertension and endothelial dysfunction: therapeutic approach","volume":"10","author":"Ghiadoni L","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/01.HYP.0000239816.13007.c9","article-title":"Effect of regular phosphodiesterase type 5 inhibition in hypertension","volume":"48","author":"Oliver JJ","year":"2006","journal-title":"Hypertension"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jacc.2011.07.051","article-title":"Cardiac uses of phosphodiesterase-5 inhibitors","volume":"59","author":"Schwartz BG","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/HJH.0000000000000021","article-title":"Pathophysiology of hypertension: interactions between macro and microvascular alterations through endothelial dysfunction","volume":"32","author":"Yannoutsos A","year":"2014","journal-title":"J Hypertens"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.2174\/1381612811319130006","article-title":"Microvascular endothelial dysfunction in obesity and hypertension","volume":"19","author":"Virdis A","year":"2013","journal-title":"Curr Pharm Des"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/FJC.0b013e3181673bc5","article-title":"Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis","volume":"51","author":"Sabino B","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/FJC.0b013e3181ce9810","article-title":"Microvascular effects of centrally acting antihypertensive drugs in spontaneously hypertensive rats","volume":"55","author":"Nascimento AR","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.amjhyper.2005.10.021","article-title":"Increased skin capillary density in treated essential hypertensive patients","volume":"19","author":"Debbabi H","year":"2006","journal-title":"Am J Hypertens"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/bjmbr\/v51n3\/1414-431X-bjmbr-1414-431X20176601.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T02:20:51Z","timestamp":1719973251000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2018000300607&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018]]}},"alternative-id":["S0100-879X2018000300607"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x20176601","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"value":"1414-431X","type":"electronic"},{"value":"0100-879X","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"article-number":"e6601"}}